These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 17531579)
1. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study). Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA; Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579 [TBL] [Abstract][Full Text] [Related]
2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Messerli F; Frishman WH; Elliott WJ Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873 [TBL] [Abstract][Full Text] [Related]
5. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group. DeQuattro V; Lee D Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890 [TBL] [Abstract][Full Text] [Related]
6. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB; Curran MP; Perry CM Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112 [TBL] [Abstract][Full Text] [Related]
7. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers. Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ; Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074 [TBL] [Abstract][Full Text] [Related]
8. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
9. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST). Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ; Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group. DeQuattro V; Lee D; Messerli F Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443 [TBL] [Abstract][Full Text] [Related]
11. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G; J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240 [TBL] [Abstract][Full Text] [Related]
12. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group. Holzgreve H; Compagnone D; Zilles P J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials. Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388 [TBL] [Abstract][Full Text] [Related]
15. Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST). Zineh I; Cooper-Dehoff RM; Wessel TR; Arant CB; Sleight P; Geiser EA; Pepine CJ Clin Cardiol; 2005 Jul; 28(7):321-8. PubMed ID: 16075824 [TBL] [Abstract][Full Text] [Related]
16. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]). Cooper-Dehoff R; Cohen JD; Bakris GL; Messerli FH; Erdine S; Hewkin AC; Kupfer S; Pepine CJ; Am J Cardiol; 2006 Oct; 98(7):890-4. PubMed ID: 16996868 [TBL] [Abstract][Full Text] [Related]
17. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study. Ruilope LM; Usan L; Segura J; Bakris GL J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814 [TBL] [Abstract][Full Text] [Related]
18. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313 [TBL] [Abstract][Full Text] [Related]
19. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil]. Widimský J; Dzúrik R Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Holzgreve H; Nakov R; Beck K; Janka HU Am J Hypertens; 2003 May; 16(5 Pt 1):381-6. PubMed ID: 12745200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]